A synthetic biology technology has been developed that converts easily degraded messenger RNA (mRNA) into a ring-shaped form inside microbial cells, increasing protein production.

A new Cochrane review led by the University of Exeter has found that programmes tailored to individual risk, known as multifactorial programmes, probably make no difference to how often people fall or the risk of falling, compared with offering falls advice or education. 

The International Society for Stem Cell Research (ISSCR) announces  the appointment of Dominique Bonnet, Ph.D., and Frederic Relaix, Ph.D., as Associate Editors of Stem Cell Reports, the official journal of the ISSCR.

Drs. Bonnet and Relaix bring internationally recognized expertise spanning hematopoietic and muscle stem cell biology, development, regeneration, disease modeling, and translational research. Their appointments further strengthen the journal’s editorial expertise across fundamental and disease-focused stem cell research.

ARDD 2026 will convene senior leaders from Novartis, Eli Lilly, Pfizer, Takeda, Menarini, GSK, AstraZeneca, Novo Nordisk and other global pharmaceutical companies alongside leading academics, regulators, investors and biotechnology innovators at Harvard University from October 1–3.

Newly announced program highlights include a pharmaceutical chief executive panel moderated by TIME Senior Health Correspondent Alice Park; an FDA and ARPA-H discussion on aligning clinical trials with regulatory mandates; and presentations from the 11 XPRIZE Healthspan finalist teams preparing aging interventions for Phase 2 clinical trials.

Dedicated forums will examine AI-enabled drug discovery, pet and animal longevity, and virtual cell models that capture biological change and aging over time. The three-day program will span aging biology, clinical development, pharmaceutical R&D, regulation, investment and the translation of longevity science into new medicines.

Now in its 13th year, ARDD brings together the scientific, commercial and regulatory leaders shaping longevity biotechnology. The meeting will take place at the David Rubenstein Treehouse at Harvard University in Boston.

A side-by-side comparison of three generations of high-sensitivity flow cytometers provides new insights into the detection and quantification of nanoparticles and extracellular vesicles, highlighting how instrument configuration, detection strategy, and sample concentration influence single-particle measurements.